| mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0083 |
0.9 |
| mRNA |
Crizotinib |
FIMM |
pan-cancer |
AAC |
0.03 |
0.9 |
| mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
| mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
| mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.9 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
| mRNA |
UNC1215 |
GDSC1000 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
| mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |